The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
4817167 6040616 I 4817167-3 20050606 20051018 PER PHEH2005US06359 NOVARTIS PHARMACEUTICALS CORP. F N 20050829 MD UNITED STATES

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
4817167 1006582324 PS ZOMETA 1 INTRAVENOUS 4 MG, INTRAVENOUS U U 21223

Indications of drugs used

Event ID DRUG SEQ INDI PT
4817167 1006582324 MULTIPLE MYELOMA

Outcome of event

Event ID OUTC COD
4817167 OT

Reactions reported

Event ID PT
4817167 BLOOD ALBUMIN DECREASED
4817167 BLOOD CALCIUM DECREASED

Reporting Sources (this data is often not reported and may therefore be missing here)

Event ID RPSR COD
4817167 CR
4817167 HP

Therapies reported

no results found